Good morning. 
Wednesday in Whitewater will be mostly cloudy with scattered showers and a high of fifty-eight. Sunrise is 5:59 AM and sunset 7:46 PM, for 13h 46m 38s of daytime. The moon is a waning crescent with 0.3% of its visible disk illuminated.
Today is the one thousand two hundred sixty-first day.
On this day in 1970, Earth Day is first celebrated.
Recommended for reading in full —
Brian Stelter writes Fox quietly abandons hydroxychloroquine:
Fox News has fallen out of love with hydroxychloroquine. After weeks of unrelenting coverage hyping the antimalarial drug as a potential game-changing treatment for the coronavirus, the network has all but stopped mentioning it on its airwaves. So has President Donald Trump.
The quite abandonment of hydroxychloroquine comes as studies indicate it is not an effective treatment against the coronavirus. A French study found last week that the drug does not help patients with the virus. And on Tuesday, a study of hundreds of patents at US Veterans Health Administration medical centers found that patients who took hydroxychloroquine were no less likely to need ventilation and had higher death rates than those who didn’t take the drug.
“Will anyone who breathlessly pitched hydroxychloroquine as a miracle drug show a modicum of regret or even self-awareness over this? Doubtful,” The Daily Beast’s Sam Stein predicted. “More likely is they’ll ignore the study entirely.” Stein appears to have been right on the money.
Despite having previously pushed the drug as a possible treatment, neither Tucker Carlson nor Sean Hannity mentioned the study on their Fox News shows Tuesday night. I didn’t see Laura Ingraham, who reportedly visited the White House to promote the drug, discuss it either. Fox published a digital story on the Tuesday study, but it fell off the website’s homepage after a few hours.
(Emphasis in original.)
The Associated Press reports ‘Small Business’ Loans Went to Big Businesses & Failing Ones:
Companies with thousands of employees, penalties from government investigations and risks of financial failure even before the coronavirus walloped the economy were among those receiving millions of dollars from a so-called “small business” relief fund that Congress created, an Associated Press investigation found.
The Paycheck Protection Program was supposed to infuse small businesses, which typically have less access to quick cash and credit, with $349 billion in emergency loans that could help keep workers on the job and bills paid on time.
But at least 75 companies that received the aid were publicly traded, the AP found, and some had market values well over $100 million. And 25% of the companies had warned investors months ago — while the economy was humming along — that their ability to remain viable was in question.
By combing through thousands of regulatory filings, the AP identified the 75 companies as recipients of a combined $300 million in low-interest, taxpayer-backed loans.
Eight companies, or their subsidiaries, received the maximum $10 million possible, including a California software company that settled a Securities and Exchange Commission investigation late last year of accounting errors that overstated its revenue.
The eight firms getting maximum loans are likely just a tip of the iceberg: Statistics released last week by the U.S. Small Business Administration showed that 4,400 of the approved loans exceeded $5 million. Overall, the size of the typical loan nationally was $206,000, according to the statistics. The SBA will forgive the loans if companies meet certain benchmarks, such as keeping employees on payroll for eight weeks.